Dexamethasone, Elotuzumab, and Pomalidomide in Treating Patients With Refractory Multiple Myeloma
NCT03713294
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
37
Enrollment
OTHER
Sponsor class
Conditions
Refractory Plasma Cell Myeloma
Interventions
DRUG:
Dexamethasone
BIOLOGICAL:
Elotuzumab
DRUG:
Pomalidomide
Sponsor
Mayo Clinic